More about AstraZeneca Pharma India Limited
Fundamentals for AstraZeneca Pharma India Limited
Regulatory Filings for AstraZeneca Pharma India Limited
From COVID Debt to Green Despair: Industrial Discharge Is Destroying India’s Last Prawn Nurseries
The Hidden Cost of India's Electronics Assembly Push: A 40% E-Waste Surge and the Death of Affordable Repair
The Wedding Loan Trap: How India’s Microfinance Boom Turned Housewives Into Ghost Borrowers and Temple Brass Into EMI Cash
From Lifesaving Drugs to Sick Units: The Hidden Energy Crisis Inside India’s Pharma Clusters
Technicals for AstraZeneca Pharma India Limited
Price Summary
AstraZeneca Pharma India Limited's stock slumped -2.59% today, marking a mediocre performance in the market.AstraZeneca Pharma India Limited's stock opened at 8431.5 on 2026-04-30, surged to 8465.5, hit a low of 8102.0, and closed up -2.59% at 8213.0, with 11231 shares traded.
In the last 52 weeks, the stock's top price was 10509.5 and the bottom price was 7765.5.
Technicals
Support and Resistance: The price of 8213.0 is supported at 8154.5 and encounters resistance at 8400.0. This suggests key levels where the price might find stability, with 8154.5 providing a base and 8400.0 acting as an upper boundary for ASTRAZEN.Aroon: The AROON is currently neutral, showing no clear bias toward an upward or downward trend. This suggests that the market may be in a phase of indecision or consolidation.
Bol. Bands: The current state of the BOLL BANDS is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
Parabolic SAR: The PSAR maintains its bearish outlook, setting a resistance level that could act as a ceiling for upward momentum. This ongoing bearish trend suggests that the market may struggle to overcome this resistance, keeping prices subdued.
Stochastic: The STOCHASTIC is in a neutral stance, with no clear direction indicated for the market. This lack of clarity suggests that the market may be in a state of equilibrium for ASTRAZEN, with no strong trend emerging.
Tripple Moving Agerage: The current reading of the Tripple MOVING AVG is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
When analyzing a company, its fundamentals—such as earnings, management efficiency, and strategic initiatives—must be considered alongside technical data. The context of the industry in which the company operates also plays a key role, as market trends and competitive dynamics can significantly impact performance. By taking a comprehensive approach, combining both fundamental and technical analysis, one can gain a deeper understanding of the company's potential for growth or risk.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
From Price Pressures to Profit Power: The MSME Playbook Redefining India’s Economy
₹90 Crore Bet Signals a Massive Shift in India’s Rural Economy
The Hidden Engine of Global Growth: Why India Is Becoming Impossible to Overlook